Colorectal Cancer Flashcards

1
Q

Colorectal cancer is a/an ______genous disease classified into different subtypes that have specific morphological and molecular characteristics

Studies have shown _____asing incidence with _______ prognosis

A

hetero

incre; dismal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Colorectal cancer is the _____ most common cancer accounting for ____% of all cancers and _____ most common
cause of (9.4%) of all cancer deaths. Globocan, 2020

A

4th; 10

2nd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Increasing Incidence of CRC
• It’s projected that global incidence will increase by ___% in 2035 with significant rise in the _______ and ______ countries

A

80

young and underdeveloped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Increasing Incidence of CRC

• Review of CRC in Nigeria have also indicated ______asing incidence in with greater proportion in (younger or older?) patients

A

incre

Younger

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Age and Gender Prevalence
• The mean ages in most studies in
Nigeria ranged from _____ to ______ years
(average of _____years).

A

39 to 50.7

46.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Age and Gender Prevalence

• M:F ratio = ——- to _____

• Patients <40years =______ %

A

1.3 to 1.

32.2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Aetiology/Predisposing factors
• CRC is a/an _____genous and _____-factorial disease

A

hetero

multi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Aetiology/Predisposing factors of CRC

• Multiple factors predispose to the disease:
•________ and ______
• host __________ disorders
•__________

A

Environmental & dietary

inflammatory GI

Genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Predisposing factors to CRC

Environmental and Dietary factors

• High content of ______ and ______
• Low content of _______________ in
diet
• Low overall __________ and ______ intake
• Low intake _____ micronutrients
• _______ and ______ consumption
• Obesity
•_______ habits

A

red meat and animal fat

un-absorbable fiber

fruits and vegetable

protective

Alcohol and tobacco

Sedentary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Protective factors against CRC

• Use of ______ (_____ ————)
• Vegetables
•______ activity
• _____________________ therapy
•_______ intake

A

NSAIDs; COX 2 inhibitors

Physical

Hormone replacement

calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Host inflammatory disorders that predispose to CRC

Inflammatory bowel diseases such as
•________________
•_______ disease
• The risk increases with ______ of the IBD and the ________ of ____________

A

Ulcerative colitis

Crohn’s; duration

extent of colonic involvement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors- Genetic (Major Familial
syndromes)

2 conditions
Mention them

A

Hereditary non-polyposis coli (HNPCC) syndrome

Familial adenomatous polyposis (FAP) syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Risk factors- Genetic

Hereditary non-polyposis coli (HNPCC) syndrome

Abnormal Genes:
Lifetime cancer risks:
Features:

A

DNA mismatch repair gene MLH1, MLSH2, MSH6, PMS2

50-80%

No polyps, microsatellite instability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Risk factors- Genetic

Familial adenomatous polyposis (FAP) syndrome

Abnormal Genes:
Lifetime cancer risks:
Features:

A

APC gene mutation in on chromosome 5q21.

100% by age , 40yrs

multiple adenomatous polyps throughout the GIT (50-500 polyps)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Classification of CRC Pathology
• CRC is a single disease

T/F

A

F

• CRC is not a single disease but a collection of multiple diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Classification of CRC Pathology

• It is highly ______genous and dynamic with multiple ______ and ______ alterations underlying its
pathogenesis.

A

hetero

genetic and epigenetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Classification of CRC Pathology

• The different subtypes have distinct clinical, morphological, and molecular characteristics which explains the differences in disease outcomes and
response to therapy

T/F

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Classification of CRC : Hereditary or acquired

Hereditary-____-___%
•____ syndrome
•____________ syndrome
• others

Sporadic -____-____%
• Complication of ________________

A

20-30 ; Lynch; Familial Polyposis

70-80; Inflammatory bowel syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Classification of CRC: Anatomic

based on location of the tumour
___________ and _________ colon cancer

A

Right sided

Left sided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Classification of CRC: Molecular

based on the _________________

A

underlying genetic abnormality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Molecular classification

• In CRC, the transformation of colonic mucosa into invasive cancer occurs through __________ or __________ changes
within the genome and epigenome

• -so-called _______ and ________ hypothesis

A

an accumulated somatic or inherited

multi-hit and multi-step

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Tumour Cancer Genome Atlas, TCGA,

____________(___%)

____________(___%)

____________(___%)

A

Hyper mutated; 13

Ultramutated; 3

Chromosomal instability;84

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Consensus Molecular Subtype

___________(_____%)

___________(_____%)

___________(_____%)

___________(_____%)

___________(_____%)

A

MSI: immune; 14

Canonical; 37

Metabolic ;13

Mesenchymal ;23

Mixed features;13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Tumour Cancer Genome Atlas, TCGA : Consensus Molecular Subtype

__________ = _________

__________ = ___________

A

Hypermutated; CMS1 : MSI immune

Chromosomal instability; canonical, metabolic, and mesenchymal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Anatomical location of: MSI immune Canonical Metabolic Mesenchymal
Right sided colon Left sided colon and rectum No predominance Typically diagnosed at more advanced stages
26
Prognosis and survival of: MSI immune Canonical Metabolic Mesenchymal
Good prognosis but poor survival after relapse Good survival after relapse Intermediate survival Worst overall and relapse-free survival
27
Treatment plan for : MSI immune Canonical Metabolic Mesenchymal
Likely benefit from immune checkpoint blockade Anti-EGFR therapies likely effective , may respond to oxali-platin based regimens Likely resistant to anti-EGFR therapies Maybe responsive to antiangiogenic therapies and perhaps more sensitive to irinotecan-based regimens
28
Colorectal carcinogenesis • The mechanisms that underlie development of CRC have been described as a “multi-hit, multi-stage” phenomenon in which •__________ mutations (alterations or changes) occur in ______ genes, after exposure to ___________ of environmental and dietary risk factors.
several multiple multiple hits
29
Colorectal carcinogenesis These mutations occur at (same or different?) stages and result in increasing _______________ from normal _____proliferative epithelium, to _________,__________ and then finally _________ As the tumour grows, it is prone to _________ that confer on it, _________________ potential
Different phenotypic abnormality; hyper small adenoma, large adenoma invasive cancer; more mutations metastatic potential
30
3 Major Pathogenetic Pathways in CRC Pathology ___________ _______________ ______________
Chromosomal instability Hypermutated (microsatellite instability) Serrated pathways
31
Chromosomal instability Hypermutated (microsatellite instability) Serrated pathways Sporadic: Hereditary:
80%; FAP 1% 15%; Lynch syndrome 3-4% 10-20%
32
Chromosomal instability _______ activation __________ inactivation (Early or Late?) abnormalities of _____ pathway
Oncogen Tumor surpressor gene Early abnormalities of WNT
33
Hypermutated (microsatellite instability) Defective ___________________
DNA mismatch repair
34
Serrated pathways Overlapping with ________________ Mutation in _______ or _______ leading to ________ of ______ pathway
CIN and MSI KRAS or BRAF hyper activation of MAPkinase
35
Chromosomal instability _____________________ sequence •________ ————
Adenoma→Carcinoma Classical adenocarcinoma
36
Hypermutated (microsatellite instability) _______ differentiated tumour •_____________ lymphocytes
Poorly Tumour infiltrating
37
Serrated pathways Premalignant lesions- • Traditional _________ (TSA) and •_____________ adenomas/______
serrated adenomas Sessile serrated polyps
38
The adenoma-carcinoma mode of mechanism of pathogenesis • This implies that ———————————————————————-
some carcinoma of the colon arise from adenoma
39
The adenoma-carcinoma mode of mechanism of pathogenesis There is cumulative alteration in the genome which results in→ increasing _____,______ of _______ & ______ potential of the tumour→carcinoma
size, level of dysplasia invasive
40
Microsatellite instability pathway • characterized by genetic abnormalities in the _________________ genes • It is responsible for ____-____% of sporadic colorectal cancers
DNA mismatch repair 10-15
41
_____________ is the main pathway in Hereditary non-polyposis coli cancer syndrome (HNPCC syndrome).
Microsatellite instability pathway
42
Microsatellite instability pathway Cancer occurs in ______ colon, tends to be _________ and in (younger or older?) age. • There is Increase incidence of ______ and ________ cancer
proximal; mucinous Younger endometrial and ovarian
43
In Microsatellite instability pathway Presence of preceding polyps. T/F
F No preceding polyps.
44
Microsatellite instability pathway abnormality may be inherited or sporadic T/F
T
45
microsatellites Are ______ (small or large?) ( DNA or RNA?) sequences scattered in the genome and are (fixed or variable?) in number for an individual They are _____________ during DNA replication
repetitive; small; DNA Fixed prone to errors
46
microsatellites are located in the _____ or _______ region of genes involved in ______ of _______
coding or promoter regulation of cell growth
47
microsatellites The mutations occur within hMLH1, hMSH2, hMSH6, hPMS1 or hPMS2. hMLH1 & hMSH2 are the most common T/F
T
48
Diagnosis of CRC _________ is taken to obtain ___________ for _______ diagnosis
Biopsy; tumour tissue; histological
49
_________ and ________ are the commonest site of CRC in Nigeria
Rectum and sigmoid colon
50
Morphology -MACROSCOPY Site: _________ and _________ colon _______ and _________ colon _________ colon
caecum and ascending Rectum and sigmoid Descending
51
Macroscopy: Right sided, Caecal tumour- ___________ Macroscopy: Left sided colon cancer __________________
fungating annular constricting
52
Morphology: Right sided, Caecal tumour-fungating In (proximal or distal?) colon (right sided tumour), they grow as: • ______________ mass along ______ of the _______ and ______ colon • Obstruction is ( common or rare?) • (Acute or Chronic?) blood loss
Proximal Polypoid fungating one wall; caecum & ascending Rare; chronic
53
Left sided colon cancer: annular constricting In (proximal or distal?) colon (lt. sided tumour) are: •________,_________ lesion that produces a _______-_____ constriction of the bowel • Obstruction and bleeding per ______ are (common or rare?)
Distal annular, encircling napkin-ring rectum; common
54
Microscopy: WHO Histologic classification of CRC ___________ ___________(_____) adenocarcinoma _____________ carcinoma
Adenocarcinoma Mucinous (colloid) Signet-ring cell
55
Microscopy: WHO Histologic classification of CRC Adenocarcinoma –most _________ , (poorly or well?) formed glands Mucinous adenocarcinoma (> ____ % ________) Signet-ring cell carcinoma (> ____ % __________)
common; well 50; mucinous 50; signet-ring cells
56
Microscopy of CRC  _________ carcinoma __________ carcinoma ________ carcinoma  ________ carcinoma  ___________ carcinoma  Others
Squamous cell Adenosquamous Medullary; Small cell Undifferentiated
57
Small cell carcinoma Aka _____ grade ___________ carcinoma
high neuroendocrine
58
Microscopy of CRC __________ is the most common, with significant proportion of (poor or good?) prognostic types
Adenocarcinoma Poor
59
Colonic adenocarcinoma (poorly or well?) differentiated _____ gland formation T__
Poorly no 3
60
Histologic grading of CRC Grade 1- _____ differentiated Grade 2 - _______ differentiated Grade 3 - ________ differentiated
Well Moderately Poorly
61
Size of primary tumor Tis- carcinoma insitu T1-tumour invades _________ T2-tumour extends to ___________ but ____________ T3-tumor is ________________ into ________ T4-(directly or indirectly?) _______________________
submucosa muscularis propria not penetrating through penetrating through muscularis propria into subserosa Directly invades surrounding structures/organs
62
TNM- Nodal metastasis (N) Nx— regional nodes _______________ N0—_____ regional node metastasis N1-metastasis in _____ nodes N2-metastasis in ________ nodes
cannot be assessed no 1-3 4 or more
63
Staging- distant metastasis (M) • Mx- metastasis __________ • M0- _____distant metastasis • M1-distant metastasis_______
cannot be assessed No present
64
Screening for CRC • ___________________ test (FOBT) • _______________________ test (FIT) • ______________________________ (DCBE), •_______________
Faecal occult blood Faecal Immunochemical Double contrast barium enema Colonoscopy
65
Clinically majority show no symptoms for several years. Later, Left sided tumour–(distal) •______/______ bleeding •Change in _______ • _______ left lower abdominal discomfort •______,______,______
Occult/frank bowel habit Crampy Malena, diarrhoea, constipation
66
Right side tumour-Proximal fatigue,weakness, ____________ anemia, __________ if bulky
iron deficiency bleeding
67
Colon Polyps Are _________ of tissue into lumen May be __________
Raised outgrowth pre-cancerous
68
Removal of colon polyps can prevent colon cancer T/F
T
69
Hyperplastic Polyp • (Benign or malignant?) • Common in ________ colon • (Normal or Abnormal?) cellular structure, ____ dysplasia
Benign rectosigmoid; normal no
70
Most common type of polyp is ???
Hyperplastic Polyp
71
Hyperplastic Polyp Classically have a “________” or _______ pattern Usually ________ screening is required after biopsy
saw tooth; serrated no special
72
Adenomatous Polyp Dysplastic with ________ potential
malignant
73
Adenomatous polyp By shape: ______ and ______
Sessile Pedunculated
74
Adenomatous polyp By histology: ______ and ______
Tubular Villous
75
Sessile vs. Pedunculated Sessile: (broad or narrow?) base attached to _____ Pedunculated: attached via _______
Broad ; colon stalk
76
Tubular vs. Villous Tubular • (Most or least?) common subtype (___%+) •________ epithelium forming ______
Most; 80 Adenomatous; tubules
77
Tubular vs. Villous Villous • (more or less?) common type • Often (sessile or pedunculated?) • (Short or Long?) projections extending from surface • (Low or High?) risk of development into colon cancer
Less; sessile Long; High
78
Polyp Symptoms Almost always (asymptomatic or symptomatic?) Screening ________ done for detection
asymptomatic colonoscopy
79
Polyp Symptoms Large polyps may cause bleeding • Usually (visible or not visible?) in stool (“______”) • Basis for screening with _______________ testing
Not visible ; occult fecal occult blood
80
High Risk Polyps Likely to develop into _____ • _______ histology •Dysplasia grade • Determined by pathologist • “______ grade dysplasia” = ↑ risk
cancer; Villous High
81
Patient likely to develop more polyps • Metachronous adenoma: new lesion ~ _________ after prior • >___ cm in diameter = ↑ risk •_______ of polyps = ↑ risk
six months 1 Number
82
Juvenile Polyps (Benign or Malignant?) tumors ( _________ ) that occur in (children or adults?) • Usually in _______ • Usually (sessile or pedunculated?) •Cause (painful or painless?) rectal bleeding • Often “____________”
Benign; hamartomas children; rectum pedunculated; painless auto-amputate
83
Juvenile polyposis syndrome •(Single or Multiple?) (usually >___) polyps • ____eased risk of cancer • Surveillance ______
Multiple 10 Incr colonoscopy
84
Cyclooxygenase-2 expression is ____eased in colon cancer
Incr
85
Chromosomal Instability Pathway “Adenoma-Carcinoma sequence” •Sequence of genetic events seen in colon cancer. Leads to colon cancer over many years • Progression probably takes ____-____ years • “_______” mutations occurs with aging •More common in _____ sided tumors •Descending colon, sigmoid, rectum
10-40 Somatic left
86
APC (____________________) protein/gene Is a __________ gene It Prevents ________ of ________ that activates __________
Adenomatous polyposis coli Tumor suppressor accumulation of β-catenin oncogenes
87
Chromosomal Instability Pathway Step 1: APC mutation • Loss of APC → ↑_______ → _______ activation • Leads to increased risk for ______
β-catenin; oncogene polyps
88
Chromosomal Instability Pathway Step 2: K-RAS mutation • Aberrant _________ Leads to ___________ formation
cell signaling adenoma polyp
89
K-RAS mutation is a ____________
Proto-oncogene
90
Chromosomal Instability Pathway Step 3: p53 • Loss of p53 _________ gene leading go Tumor ________ •
tumor suppressor cell growth
91
Chromosomal Instability Pathway Step 1:__________ causes a ______ Step 2:____________ leads to ______ Step 3: ________ ends in _____
APC mutation; high risk colon KRAS mutation; polyps formation Loss of P53; colon cancer
92
FAP Familial Adenomatous Polyposis (Autosomal or X-linked?) (dominant or recessive ?) disorder _______ mutation of ____ gene (chromosome ____) (Always or sometimes?) (_____%) progresses to colon cancer
Autosomal dominant Germline; APC; 5q Always ; 100
93
FAP Familial Adenomatous Polyposis Treatment: _________(____)
Colon removal (colectomy)
94
Microsatellite Instability pathway can arise without polyps T/F
T Microsatellite Instability can arise “de novo” without polyp
95
microsatellite? •usually (coding or non-coding?) • (Same or Different?) density as/from other DNA • (Same as or Separate from?) other genetic material in testing (“satellites”)
Non coding Different Seperate from
96
a stable microsatellite •Successive cellular divisions: _____________ microsatellites •Each person has unique, ___________ of microsatellites • Different person-to-person; same for each individual
same length “stable” length
97
_________ enzymes resolve base errors
Mismatch repair
98
Examples of Mismatch repair enzymes E.g: _____,_______,_______,_______ etc
MLH1, MSH2, MSH6, PMS2
99
Microsatellite Instability __________ can lead to accumulation of errors . This can occur in ________ in cancer cells Result is ______________
Gene mutations microsatellites microsatellite instability
100
Microsatellite Instability •_____ testing • Different _____ of microsatellites in tumor cells vs other cells • Indicates ______________ dysfunction
PCR length mismatch repair enzyme
101
Colon Cancer Screening CEA (______________) Tumor marker (Elevated or depressed?) in colon CA and other tumors (pancreas) (Poor or excellent?) sensitivity/specificity for screening
Carcinoembryonic Antigen Elevated Poor
102
Colon Cancer Screening CEA Patients with established disease • CEA level correlates with ________ • Elevated levels should return to baseline after ________ • Can be monitored to ________
disease burden surgery detect relapse
103
HNPCC _____________ Cancer/ _____ Syndrome Inherited mutation of ___________ Leads to colon cancer via __________ • About ____% lifetime risk
Hereditary Non-Polyposis Colorectal ; Lynch DNA mismatch repair enzymes microsatellite instability ; 80
104
Colon Cancer Screening HNPCC • Arise with pre-existing adenoma T/F
F Arise with out pre-existing adenoma
105
HNPCC Usually ______-sided tumors Also increased risk of: •_________ cancer , Other cancers (ovary, stomach, others)
right Endometrial
106
HNPCC Classic case • Patient with ______ sided colon CA • (Single or Multiple?) ___________ members also with cancer
right Multiple 1st family
107
__________ cancer is most common non-colon malignancy
Endometrial